Used primarily in research settings as a selective inhibitor of fatty acid synthase (FASN), an enzyme overexpressed in various cancer cells. It demonstrates potent anti-proliferative effects in multiple tumor cell lines, making it a valuable tool compound in oncology studies. It has been investigated for its ability to induce apoptosis and suppress tumor growth in preclinical models, particularly in prostate, breast, and colorectal cancers. Its role in disrupting lipid metabolism in cancer cells supports ongoing exploration into metabolic pathways as therapeutic targets. Not intended for clinical use; restricted to laboratory research.